Revised SPCs: Sevodyne (buprenorphine) transdermal patch – all strengths
SPC updated to warn that for all patients, prolonged use may lead to drug dependence, even at therapeutic doses; and risks are increased in individuals with current or past history of substance misuse disorder or mental health disorder.
Source:
electronic Medicines compendium